Two new intraocular lenses (IOLs) that restore vision to people with cataracts are now available in the United States. The new TECNIS ® Multifocal IOLs, developed by Abbott (NYSE: ABT), provide people ...

With the recent FDA approval of two new Abbott Medical Optics Tecnis multifocal IOL models with lower add powers, we now have a family of multifocal IOLs that gives surgeons more choices to achieve ...

Please provide your email address to receive an email when new articles are posted on . An aspheric, bifocal, diffractive multifocal IOL with low near addition restored near, intermediate and distance ...

Santa Ana-based Abbott Medical Optics continues to forge ahead with new products. The maker of eye devices, a unit of Chicago-based Abbott Laboratories, recently introduced two versions of its Tecnis ...

ABBOTT PARK, Ill., June 24, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received CE Marking (Conformite Europeenne) in Europe for the TECNIS ® Symfony Extended Range of Vision ...

Two new intraocular lenses (IOLs) that restore vision to people with cataracts are now available in the United States. The new TECNIS Multifocal IOLs, developed by Abbott, provide people with ...

TECNIS Odyssey IOL offers higher tolerance to residual refractive errors, enabling surgeons to deliver consistent and reliable patient outcomes. 5¶ Experience the ...

STOCKHOLM, Sweden--(BUSINESS WIRE)--Advanced Medical Optics, Inc. (AMO) (NYSE:EYE) today announced from the XXV Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) the launch ...

Johnson & Johnson Vision (JNJ) has received approval in the US for TECNIS Synergy and TECNIS Synergy Toric II IOLs. In Canada, it received approval for TECNIS Synergy Toric II IOLs. This ...